Pierre Frouin

Pierre Frouin is an accomplished investor and board member with extensive experience in the biomedical and technology sectors. Currently serving as an Investor/LP at Newfund, Emblem, and GO CAPITAL, as well as a Board Member at Niryo, Frouin has a strong track record in angel investing. Frouin founded BioSerenity, a DeepTech Medical Device company, which achieved over 40 million euros in revenue, introducing innovative products in Neurology, Sleep Disorders, and Cardiology. Academic roles include Adjunct Professor at Georgia State University's Institute for Biomedical Sciences, while also pursuing a PhD in Neuroscience at Université Paris-Saclay. Frouin's previous positions include leadership roles in marketing and sales at Johnson & Johnson, and ERP management at BIOGARAN, demonstrating a solid foundation in both business and technology. Educational credentials comprise an MBA from INSEAD and participation in the StartX Med program at Stanford University.